©The Author(s) 2026.
World J Gastrointest Surg. Jan 27, 2026; 18(1): 115201
Published online Jan 27, 2026. doi: 10.4240/wjgs.v18.i1.115201
Published online Jan 27, 2026. doi: 10.4240/wjgs.v18.i1.115201
Table 1 General information, n (%)
| Control group (n = 55) | Combination group (n = 55) | t/χ2 | P value | |
| Gender | 0.147 | 0.702 | ||
| Male | 26 (47.27) | 24 (43.64) | ||
| Female | 29 (52.73) | 31 (56.36) | ||
| Age (years) | 68.23 ± 3.01 | 67.84 ± 3.24 | 0.574 | 0.567 |
| BMI (kg/m2) | 22.03 ± 2.42 | 21.72 ± 2.25 | 0.700 | 0.486 |
| Infarction location | 0.825 | 0.843 | ||
| Brainstem | 10 (18.18) | 9 (16.36) | ||
| Cerebral lobe | 14 (25.45) | 15 (27.27) | ||
| Basal ganglia | 29 (52.73) | 27 (49.09) | ||
| Others | 2 (3.64) | 4 (7.27) |
- Citation: Chen XX, Han XF, Chu Y. Naloxone plus enteral nutrition for gastrointestinal dysfunction in elderly cerebral infarction and peptic ulcer patients. World J Gastrointest Surg 2026; 18(1): 115201
- URL: https://www.wjgnet.com/1948-9366/full/v18/i1/115201.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v18.i1.115201